The case for Emerald Health Therapeutics

Emerald Health and Organigram are competing against larger players with more cash to fund retail operations. If the market for recreational marijuana in Canada isn’t as big as predicted, both of these stocks will suffer. There’s also the possibility that the scramble among marijuana growers to expand … Read More

The post The case for Emerald Health Therapeutics appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *